Tanfac Industries Share Price
Sector: Chemical Manufacturing
3677.05 +281.40 (8.29%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
3402.20
Today’s High
3739.95
52 Week Low
1890.00
52 Week High
3970.00
Key Metrics
- Market Cap (In Cr) 3667.59
- Beta 1.56
- Div. Yield (%) 0.24
- P/B 11.76
- TTM P/E 32.81
- Sector P/E 17.63
- D/E 0
- Open Price 3438
- Prev Close 3395.65
Tanfac Industries Analysis
Price Analysis
-
1 Week10.01%
-
3 Months26.85%
-
6 Month22.61%
-
YTD25.71%
-
1 Year70.52%
Risk Meter
- 58% Low risk
- 58% Moderate risk
- 58% Balanced Risk
- 58% High risk
- 58% Extreme risk
Tanfac Industries News
Coffee can investing: These 5 small cap stocks meet Saurabh Mukherjea’s criteria
6 min read . 05 Mar 2025These five stocks have rallied up to 70% during the smids bloodbath
6 min read . 18 Feb 2025These 5 aluminium stocks are set to benefit from Russian giant’s production cuts
6 min read . 28 Nov 2024Reliance, Mahindra Logistics among 22 firms to post Q4 results today
1 min read . 22 Apr 2024Tanfac Industries Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 556.98
- Selling/ General/ Admin Expenses Total
- 22.91
- Depreciation/ Amortization
- 10.46
- Other Operating Expenses Total
- 61.65
- Total Operating Expense
- 438.58
- Operating Income
- 118.4
- Net Income Before Taxes
- 118.76
- Net Income
- 88.15
- Diluted Normalized EPS
- 88.37
- Period
- 2025
- Total Assets
- 426.41
- Total Liabilities
- 114.44
- Total Equity
- 311.97
- Tangible Book Valueper Share Common Eq
- 312.76
- Period
- 2025
- Cashfrom Operating Activities
- 32.84
- Cashfrom Investing Activities
- -41.69
- Cashfrom Financing Activities
- 31.85
- Net Changein Cash
- 23
- Period
- 2024
- Total Revenue
- 378.15
- Selling/ General/ Admin Expenses Total
- 31.58
- Depreciation/ Amortization
- 7
- Other Operating Expenses Total
- 21.49
- Total Operating Expense
- 311.02
- Operating Income
- 67.12
- Net Income Before Taxes
- 70.06
- Net Income
- 52.48
- Diluted Normalized EPS
- 52.62
- Period
- 2024
- Total Assets
- 301.01
- Total Liabilities
- 70.57
- Total Equity
- 230.45
- Tangible Book Valueper Share Common Eq
- 231.02
- Period
- 2024
- Cashfrom Operating Activities
- 34.23
- Cashfrom Investing Activities
- -30.37
- Cashfrom Financing Activities
- -7.21
- Net Changein Cash
- -3.35
- Period
- 2023
- Total Revenue
- 374.95
- Selling/ General/ Admin Expenses Total
- 29.12
- Depreciation/ Amortization
- 6.33
- Other Operating Expenses Total
- 17.08
- Total Operating Expense
- 304.94
- Operating Income
- 70.01
- Net Income Before Taxes
- 75.46
- Net Income
- 56.13
- Diluted Normalized EPS
- 56.28
- Period
- 2023
- Total Assets
- 251.81
- Total Liabilities
- 67.53
- Total Equity
- 184.27
- Tangible Book Valueper Share Common Eq
- 184.74
- Period
- 2023
- Cashfrom Operating Activities
- 42.94
- Cashfrom Investing Activities
- -39.59
- Cashfrom Financing Activities
- -6.37
- Net Changein Cash
- -3.03
- Period
- 2022
- Total Revenue
- 320.17
- Selling/ General/ Admin Expenses Total
- 22.7
- Depreciation/ Amortization
- 5.6
- Other Operating Expenses Total
- 14.73
- Total Operating Expense
- 248.52
- Operating Income
- 71.65
- Net Income Before Taxes
- 71.95
- Net Income
- 53.28
- Diluted Normalized EPS
- 53.29
- Period
- 2022
- Total Assets
- 182.32
- Total Liabilities
- 48.63
- Total Equity
- 133.69
- Tangible Book Valueper Share Common Eq
- 134.03
- Period
- 2022
- Cashfrom Operating Activities
- 45.17
- Cashfrom Investing Activities
- -36.12
- Cashfrom Financing Activities
- -4.51
- Net Changein Cash
- 4.54
- Period
- 2021
- Total Revenue
- 147.9
- Selling/ General/ Admin Expenses Total
- 19.5
- Depreciation/ Amortization
- 8.47
- Other Operating Expenses Total
- 7.29
- Total Operating Expense
- 123.02
- Operating Income
- 24.88
- Net Income Before Taxes
- 25.06
- Net Income
- 17.47
- Diluted Normalized EPS
- 17.52
- Period
- 2021
- Total Assets
- 120.27
- Total Liabilities
- 37.03
- Total Equity
- 83.24
- Tangible Book Valueper Share Common Eq
- 83.44
- Period
- 2021
- Cashfrom Operating Activities
- 37.21
- Cashfrom Investing Activities
- -33.92
- Cashfrom Financing Activities
- -0.91
- Net Changein Cash
- 2.38
- Period
- 2020
- Total Revenue
- 164.8
- Selling/ General/ Admin Expenses Total
- 12.5
- Depreciation/ Amortization
- 4.64
- Other Operating Expenses Total
- 17.39
- Total Operating Expense
- 142.41
- Operating Income
- 22.4
- Net Income Before Taxes
- 21.62
- Net Income
- 16.97
- Diluted Normalized EPS
- 17.02
- Period
- 2020
- Total Assets
- 89.1
- Total Liabilities
- 23.9
- Total Equity
- 65.2
- Tangible Book Valueper Share Common Eq
- 65.36
- Period
- 2020
- Cashfrom Operating Activities
- 21.81
- Cashfrom Investing Activities
- -9.46
- Cashfrom Financing Activities
- -12.36
- Net Changein Cash
- -0.01
- Period
- 2025-03-31
- Total Revenue
- 171.95
- Selling/ General/ Admin Expenses Total
- 6.61
- Depreciation/ Amortization
- 3.81
- Other Operating Expenses Total
- 17.56
- Total Operating Expense
- 140
- Operating Income
- 31.95
- Net Income Before Taxes
- 31.2
- Net Income
- 22.74
- Diluted Normalized EPS
- 22.79
- Period
- 2025-03-31
- Total Assets
- 426.41
- Total Liabilities
- 114.44
- Total Equity
- 311.97
- Tangible Book Valueper Share Common Eq
- 312.76
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 32.84
- Cashfrom Investing Activities
- -41.69
- Cashfrom Financing Activities
- 31.85
- Net Changein Cash
- 23
- Period
- 2024-12-31
- Total Revenue
- 178.18
- Selling/ General/ Admin Expenses Total
- 5.49
- Depreciation/ Amortization
- 3.24
- Other Operating Expenses Total
- 15.98
- Total Operating Expense
- 131.11
- Operating Income
- 47.07
- Net Income Before Taxes
- 46.47
- Net Income
- 34.8
- Diluted Normalized EPS
- 34.89
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 111.51
- Selling/ General/ Admin Expenses Total
- 5.66
- Depreciation/ Amortization
- 1.73
- Other Operating Expenses Total
- 15.51
- Total Operating Expense
- 86.08
- Operating Income
- 25.43
- Net Income Before Taxes
- 25.96
- Net Income
- 19.31
- Diluted Normalized EPS
- 19.36
- Period
- 2024-09-30
- Total Assets
- 360.25
- Total Liabilities
- 98.77
- Total Equity
- 261.48
- Tangible Book Valueper Share Common Eq
- 262.14
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -17.91
- Cashfrom Investing Activities
- -7.25
- Cashfrom Financing Activities
- 34.11
- Net Changein Cash
- 8.94
- Period
- 2024-06-30
- Total Revenue
- 95.35
- Selling/ General/ Admin Expenses Total
- 5.15
- Depreciation/ Amortization
- 1.68
- Other Operating Expenses Total
- 12.6
- Total Operating Expense
- 81.39
- Operating Income
- 13.96
- Net Income Before Taxes
- 15.14
- Net Income
- 11.29
- Diluted Normalized EPS
- 11.32
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 102.81
- Selling/ General/ Admin Expenses Total
- 4.61
- Depreciation/ Amortization
- 1.83
- Other Operating Expenses Total
- 12.45
- Total Operating Expense
- 88.29
- Operating Income
- 14.52
- Net Income Before Taxes
- 16.37
- Net Income
- 12.64
- Diluted Normalized EPS
- 12.67
- Period
- 2024-03-31
- Total Assets
- 301.01
- Total Liabilities
- 70.57
- Total Equity
- 230.45
- Tangible Book Valueper Share Common Eq
- 231.02
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 34.23
- Cashfrom Investing Activities
- -30.37
- Cashfrom Financing Activities
- -7.21
- Net Changein Cash
- -3.35
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Tanfac Industries Technical
Moving Average
SMA
- 5 Day3416.01
- 10 Day3392.67
- 20 Day3264.12
- 50 Day3174.18
- 100 Day3196.25
- 300 Day2755.13
Tanfac Industries Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rossari Biotech
- 682.35
- 3.85
- 0.57
- 966
- 568.05
- 3769.88
- Vishnu Chemicals
- 536.7
- -16.8
- -3.04
- 586
- 340
- 3612.81
- Tanfac Industries
- 3677.05
- 281.4
- 8.29
- 3970
- 1890
- 3667.59
- Kiri Industries
- 580.55
- -5.5
- -0.94
- 752.75
- 316.55
- 3229.82
- Mangalore Chemicals And Fert
- 269.45
- 1.1
- 0.41
- 301.35
- 115.95
- 3193.39
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rossari Biotech
- 27.55
- 3.17
- 14.11
- 7.12
- Vishnu Chemicals
- 28.82
- 4.03
- 22.52
- 8.28
- Tanfac Industries
- 38.43
- 10.86
- 32.61
- 15.04
- Kiri Industries
- 13.69
- 0.94
- 8.92
- 22.52
- Mangalore Chemicals And Fert
- 22.18
- 2.99
- 15.32
- 3.72
Tanfac Industries Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-Apr-25
- Audited Results & Dividend
- 24-Jan-25
- Quarterly Results
- 23-Oct-24
- Quarterly Results
- 19-Jul-24
- Quarterly Results
- 22-Apr-24
- Audited Results & Final Dividend
- 23-Jan-24
- Quarterly Results
- 20-Oct-23
- Quarterly Results
- 17-Jul-23
- Quarterly Results
- 21-Apr-23
- Audited Results
- 20-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 12-Jun-25
- 12-May-25
- POM
- 21-Mar-25
- 17-Feb-25
- POM
- 27-Sept-24
- 17-Sept-24
- AGM
- 27-Sept-23
- 06-Sept-23
- AGM
- 07-Jun-22
- 09-May-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-Apr-25
- -
- -
- 9
- 22-Apr-24
- -
- 20-Sept-24
- 7
- 21-Apr-23
- 20-Sept-23
- 20-Sept-23
- 6.5
- 06-May-22
- -
- 16-Sept-22
- 5.5
- 13-Aug-21
- 26-Aug-21
- 25-Aug-21
- 3.5


